載入...
Update on clinical research and state of the art management of patients with advanced sarcomas and GIST
Sarcomas constitute a rare group of malignancies. According to histology, different treatment options are effective. For gastrointestinal stromal tumours (GISTs), targeted treatment with imatinib controls about 20% of advanced or metastatic disease, whereas chemotherapy is more effective for the res...
Na minha lista:
| 發表在: | ESMO Open |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070248/ https://ncbi.nlm.nih.gov/pubmed/27843616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000065 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|